Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Penwest Begins A0001 Phase IIa Trial
A0001 or alpha-tocopherolquinone, is a coenzyme Q analog demonstrated to improve mitochondrial function in-vitro. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England.
A0001 or alpha-tocopherolquinone, is a coenzyme Q analog demonstrated to improve mitochondrial function in-vitro. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England.
Takeda has been evaluating all published data and communications from the FDA regarding the potential risks associated with concomitant use of clopidogrel and PPIs. The clinical trial, titled
LIPO-102 is a new, minimally-invasive, non-ablative approach to localised fat reduction comprising an injectable aqueous combination of salmeterol xinafoate (SX) and fluticasone propionate (FP). Reportedly, the Phase I
The license agreement covers extensive intellectual property rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world. The portfolio of intellectual property
The company plans to exploit a recently elucidated nasal-cerebral drug delivery route for targeting pain transmission and control pathways in cranial nerves and the CNS, enabling vast new
Sohm said that the strategic alliance with the manufacturing house currently has a range of 85 products covering major therapeutic categories and marketing within the northern region of
The primary endpoint in the double-blind safety study is evaluation of blood pressure effects of subcutaneous Bremelanotide in men between 45 and 65 years old. The study is
Ligon is expected to apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Patrick Kleyn, CEO of
Millipore’s current research with BDI is focused on developing new technology platforms for in-process testing and real-time monitoring in biopharmaceutical manufacturing. Dennis Harris, chief scientific officer at Millipore,
Reportedly, iCyt plans to develop advanced technologies and deliver new products in collaboration with Sony. Gary Durack will continue to lead the company through this period of growth